Government watchdog recommends tweaks to FDA accelerated approval program

16th January 2025 Uncategorised 0

A government watchdog examining the FDA’s accelerated approval pathway has released a report concluding that the agency’s controversial endorsement of Biogen’s failed Alzheimer’s treatment Aduhelm was generally an outlier. But the OIG also suggested tweaks to the approval program.

More: Government watchdog recommends tweaks to FDA accelerated approval program
Source: fierce